Premier Alternatives

Elixirgen Therapeutics

Baltimore, MD · Founded 2012 · Privately Held (backing)

Developer of stem cell therapies designed for treating syndrome and Alzheimer's diseases through regenerative and rejuvenating medicines. Elixirgen Therapeutics is based in Baltimore, MD and was founded in 2012. Its last reported valuation was $67 million in Nov 2023. It has raised $29.1 million across 8 recorded rounds; the latest was a $4 million seed round in Oct 2025.

Last reported valuation
$67.0M
Nov 2026
Priced at
—
Total raised
$29.1M
Last round
Seed Round
Oct 2025

Who backs Elixirgen Therapeutics?

2 investors
InvestorType
The University of Tokyo Edge CapitalOther
Sunovion Pharmaceuticals—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Elixirgen Therapeutics investors

2 investors are on record for Elixirgen Therapeutics, including The University of Tokyo Edge Capital and Sunovion Pharmaceuticals. The seed round in Oct 2025 drew 1 investor.

For fundraisers
Work this list, don’t just read it

These 2 firms already write checks for companies like Elixirgen Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View